Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Aristea Therapeutics, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of HS for at least 1 year prior to screening
HS lesions must be present in at least 2 distinct anatomic areas
A total AN count (sum of abscesses and inflammatory nodules) \> 6 across all anatomical sites at both the screening and baseline visits
Willing to use contraception for the duration of the study
You may not be if
Presence of other skin conditions which may interfere with study assessments
Presence of active, chronic or latent bacterial, viral, fungal mycobacterial infection (including latent TB) or history of infection within 4 weeks of screening
